Litcius/Paper detail

Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action

Damiano Tanini, Simone Carradori, Antonella Capperucci, Lucrezia Lupori, Susi Zara, Marta Ferraroni, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Laura Micheli, Elena Lucarini, Fabrizio Carta, Andrea Angeli, Claudiu T. Supuran

2021European Journal of Medicinal Chemistry35 citationsDOIOpen Access PDF

Topics & Concepts

Neuropathic painChemistryPharmacologyCisplatinOxaliplatinDoxorubicinPeripheral neuropathyCarbonic anhydraseChemotherapyCancerEnzymeMedicineBiochemistryColorectal cancerInternal medicineEndocrinologyDiabetes mellitusEnzyme function and inhibitionSynthesis and Catalytic ReactionsCholinesterase and Neurodegenerative Diseases
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action | Litcius